Tnmd Antibody

What is tenomodulin and why is it significant in scientific research?

Tenomodulin (TNMD) is a type II transmembrane protein belonging to the chondromodulin-1 family containing a BRICHOS domain. It is primarily expressed in tendons, ligaments, and adipose tissue. TNMD's significance stems from its multifunctional roles:

• Functions as a potential angiogenesis inhibitor

• Essential for proper tendon tissue adaptation to mechanical stress

• Promotes human adipocyte differentiation and improves insulin sensitivity

• Critical for collagen I fiber structural and biomechanical properties

TNMD has several alternative names in the literature, including TeM, BRICD4, CHM1L, BRICHOS domain containing 4, Chondromodulin-1-like protein, Myodulin, and Tendin .

What is the molecular structure and characteristics of TNMD protein?

TNMD is a single-pass type II membrane protein with the following characteristics:

• Predicted molecular weight: 37.1 kDa

• Contains one BRICHOS domain

• C-terminal domain (CTD) that can be released from the protein

• Co-localizes with collagen I fibers in the extracellular matrix

• Located on chromosome X in mice

The protein's structural features enable its interaction with extracellular matrix components, particularly collagen I fibers, which is critical for its function in tendon development and maintenance .

What species reactivity do commercially available TNMD antibodies typically exhibit?

TNMD antibodies demonstrate cross-reactivity across multiple species due to high sequence conservation. Available antibodies react with:

Many antibodies recognize epitopes with high sequence homology across species. For example, some antibodies recognize regions with 100% identity in human, mouse, rat, dog, bovine, horse, and pig, while having 92% identity in guinea pig and 84% in zebrafish .

What are the primary applications for TNMD antibodies in research?

TNMD antibodies are validated for multiple experimental applications:

For optimal Western blot results, incubate membranes with diluted antibody in 5% w/v milk, 1X TBS, 0.1% Tween 20 at 4°C with gentle shaking overnight .

How should researchers validate TNMD antibodies for their specific experimental needs?

Validation is critical for ensuring antibody specificity and reliability:

• Positive and negative controls:

  • Use known TNMD-expressing tissues (tendons, adipose tissue) as positive controls

  • Include TNMD knockout tissues or cells when available

  • Use blocking peptides for validation (e.g., pre-incubation of antibody with immunizing peptide)

• Cross-validation methods:

  • Compare results using multiple antibodies targeting different TNMD epitopes

  • Confirm results using genetic approaches (siRNA knockdown, CRISPR knockout)

  • Validate specificity through immunoprecipitation followed by mass spectrometry

• Application-specific validation:

  • For IHC: Test different antigen retrieval methods (e.g., boiling in sodium citrate buffer (0.01M, pH6) for 15 minutes)

  • For WB: Test different blocking solutions and antibody dilutions

  • Include appropriate secondary antibody-only controls

What tissue preparation and antigen retrieval methods are optimal for TNMD immunohistochemistry?

For successful TNMD immunohistochemistry, follow these procedures:

• Tissue fixation and embedding:

  • Fix tissues in formalin or paraformaldehyde (typically 4%)

  • Embed in paraffin following standard protocols

  • Section tissues at 5-7 μm thickness

• Antigen retrieval protocols:

  • Heat-mediated antigen retrieval in sodium citrate buffer (0.01M, pH6) for 15 minutes

  • Block endogenous peroxidase with 3% hydrogen peroxide for 30 minutes

  • Use normal goat serum as blocking buffer at 37°C for 20 minutes

• Antibody incubation:

  • Primary antibody dilution typically at 1:400 (may vary by antibody)

  • Incubate overnight at 4°C

  • For secondary detection, horseradish peroxidase (HRP)-conjugated anti-rabbit IgG followed by DAB staining works well

• Counterstaining and visualization:

  • Counterstain with hematoxylin for nuclei visualization

  • For co-localization studies, TNMD antibodies can be paired with extracellular matrix proteins like collagen I

How does TNMD function in tendon adaptation to mechanical stress?

TNMD plays a crucial role in tendon mechanobiology:

• Mechanosensitivity: TNMD is a mechanosensitive gene with promoter activity and transcription responsive to mechanical stretching

• Structural interactions: TNMD protein co-localizes with collagen I fibers in the extracellular matrix

• Functional impact: TNMD knockout mice exhibit:

  • Significantly inferior endurance running performance

  • Worsening performance with training

  • Abnormal response of collagen I cross-linking

  • Altered proteoglycan gene expression

  • Inadequate collagen I fiber thickness and elasticity

Research findings demonstrate that TNMD is required for proper tendon tissue adaptation to endurance running and maintains structurally and functionally integral collagen fibrils. The absence of TNMD leads to significantly thicker and stiffer collagen I fibers and altered crosslinking gene expression .

What is the role of TNMD in adipocyte differentiation and insulin sensitivity?

TNMD has emerged as an important regulator of adipose tissue function:

• Expression pattern: TNMD is upregulated in adipose tissue of insulin-resistant versus insulin-sensitive individuals matched for BMI

• Differentiation role: TNMD expression increases during human preadipocyte differentiation, while silencing TNMD blocks adipogenesis

• Transgenic models: TNMD transgenic mice on high-fat diets show:

  • Increased epididymal white adipose tissue (eWAT) mass

  • Greater preadipocyte proliferation

  • Upregulation of lipogenic genes in eWAT

  • Upregulation of Ucp1 in brown fat

  • Attenuated liver triglyceride accumulation

Despite expanded eWAT, transgenic animals display improved systemic insulin sensitivity, decreased collagen deposition and inflammation in eWAT, and increased insulin stimulation of Akt phosphorylation. These findings suggest that TNMD acts as a protective factor in visceral adipose tissue to alleviate insulin resistance in obesity .

What experimental approaches are recommended for studying TNMD's role in angiogenesis inhibition?

To investigate TNMD's reported angiogenesis inhibition properties:

• In vitro assays:

  • Endothelial cell tube formation assays using recombinant TNMD or conditioned media

  • Endothelial cell migration and proliferation assays

  • Co-culture systems with TNMD-expressing cells and endothelial cells

• In vivo models:

  • Matrigel plug assays with TNMD-expressing cells or recombinant protein

  • Tumor xenograft models comparing vascularization in TNMD-expressing versus control tumors

  • TNMD knockout mice analyzing vascular density in tendons and other TNMD-expressing tissues

• Molecular mechanism investigations:

  • Receptor identification using co-immunoprecipitation with TNMD antibodies

  • Signaling pathway analysis in endothelial cells treated with TNMD

  • Structure-function analysis of TNMD domains using deletion mutants

• Antibody-based approaches:

  • Neutralizing TNMD function using specific antibodies against functional domains

  • Imaging vessel formation in tissues using TNMD antibodies alongside vascular markers

What are common troubleshooting issues when using TNMD antibodies in Western blotting?

For optimal Western blot conditions:

• Incubate membranes with diluted antibody in 5% w/v milk, 1X TBS, 0.1% Tween 20 at 4°C with gentle shaking overnight

• For problematic antibodies, try alternative blocking buffers (BSA, casein, commercial alternatives)

• Include appropriate controls including blocking peptides when available

How can researchers optimize immunohistochemistry protocols for TNMD detection?

For optimal TNMD immunohistochemistry results:

• Antigen retrieval optimization:

  • Compare heat-mediated methods (microwave, pressure cooker) versus enzymatic methods

  • Test different buffers: citrate buffer (pH 6.0), EDTA buffer (pH 8.0), or Tris-EDTA (pH 9.0)

  • Optimize retrieval times (10-30 minutes)

• Signal amplification methods:

  • Consider tyramide signal amplification for weak signals

  • Use polymer-based detection systems for improved sensitivity

  • For fluorescence, try fluorophore-conjugated secondary antibodies versus streptavidin-biotin systems

• Background reduction:

  • Block with appropriate serum (from the same species as the secondary antibody)

  • Add 0.1-0.3% Triton X-100 or 0.1-0.5% saponin for improved penetration

  • For tissue with high endogenous peroxidase, extend hydrogen peroxide blocking (up to 30 minutes)

• Detailed optimization protocol:

  • Start with manufacturer's recommended dilution, then test a dilution series

  • Test various incubation times and temperatures for primary antibody (overnight at 4°C often works best)

  • Use positive control tissues known to express TNMD (tendon, adipose tissue)

What are the best methodological approaches for studying TNMD-collagen interactions?

To investigate TNMD-collagen interactions effectively:

• Co-localization studies:

  • Dual immunofluorescence with anti-TNMD and anti-collagen I antibodies

  • Super-resolution microscopy for detailed interaction analysis

  • Proximity ligation assays to confirm close spatial association

• Biochemical interaction analysis:

  • Co-immunoprecipitation using TNMD antibodies followed by collagen detection

  • Surface plasmon resonance with purified proteins

  • Solid-phase binding assays with recombinant TNMD and collagen fragments

• Functional studies:

  • Atomic force microscopy (AFM) to analyze collagen fiber topography, diameter distribution, and stiffness in wild-type versus TNMD knockout tissues

  • Mechanical testing of tendons comparing wild-type and TNMD-deficient tissues

  • Gene expression analysis of collagen crosslinking genes in response to TNMD manipulation

• In vivo models:

  • Compare collagen structure in TNMD knockout versus wildtype mice using second harmonic generation imaging

  • Analyze the effect of endurance training on collagen organization and biomechanical properties in presence/absence of TNMD

These methodological approaches have revealed that TNMD influences collagen I fiber structural and mechanical properties, with TNMD knockout tendons showing significantly thicker and stiffer collagen I fibers and altered crosslinking gene expression .

How can TNMD antibodies be used to investigate its role in pathological conditions?

TNMD antibodies can advance understanding of various pathological conditions:

• Tendinopathies and tendon injuries:

  • Analyze TNMD expression patterns in healthy versus diseased tendons

  • Study TNMD levels during tendon healing and regeneration

  • Investigate correlations between TNMD expression and clinical outcomes

• Metabolic disorders:

  • Compare TNMD levels in adipose tissues from insulin-sensitive versus insulin-resistant individuals

  • Analyze TNMD expression changes in response to weight loss interventions

  • Investigate TNMD as a potential biomarker for metabolic health

• Vascular diseases:

  • Study TNMD expression in tissues with aberrant angiogenesis

  • Investigate TNMD's potential as an anti-angiogenic therapeutic target

  • Analyze TNMD expression in tumors with varying degrees of vascularization

• Inflammatory conditions:

  • Examine TNMD's relationship with inflammation markers

  • Study TNMD expression in models of inflammatory diseases

  • Investigate whether TNMD can serve as a target for anti-inflammatory therapies

Research has shown correlations between TNMD and various conditions including inflammation, weight loss, mental disorders, hyperglycemia, vascular diseases, and glucose intolerance .

What advances in TNMD antibody technology are enhancing research capabilities?

Recent technological advances in TNMD antibody development and applications include:

• Increased specificity and validation:

  • Antibodies targeting specific domains of TNMD (N-terminal, C-terminal, BRICHOS domain)

  • Extensive cross-species validation for comparative studies

  • Rigorous validation through knockout controls and peptide blocking

• Expanded conjugate options:

  • Directly conjugated antibodies with various fluorophores (Alexa Fluor 546, Alexa Fluor 594, Cy7)

  • Enzyme-conjugated options for enhanced detection sensitivity

  • Magnetic bead conjugates for isolation and purification applications

• Advanced applications:

  • Super-resolution microscopy compatible formulations

  • ChIP-validated antibodies for transcriptional regulation studies

  • Mass cytometry (CyTOF) compatible antibodies for high-dimensional analysis

• Recombinant antibody technology:

  • Monoclonal recombinant antibodies with consistent performance

  • Fragment antibodies (Fab, scFv) for improved tissue penetration

  • Humanized antibodies for potential therapeutic applications

These advances are expanding the toolkit available to researchers investigating TNMD's complex biological functions and potential clinical applications .

How can researchers best design studies to investigate TNMD's mechanosensitive properties?

To effectively study TNMD's mechanosensitive properties:

• In vitro mechanical stimulation models:

  • Utilize bioreactors applying controlled cyclic stretching to tenocytes or adipocytes

  • Apply fluid shear stress to cells expressing TNMD

  • Use micropattern substrates with varying stiffness to analyze TNMD expression

• Promoter activity analysis:

  • Create TNMD promoter-reporter constructs to monitor activity under mechanical stimulation

  • Perform ChIP assays using transcription factor antibodies to identify mechanosensitive regulators

  • Analyze epigenetic modifications of the TNMD promoter in response to mechanical stimuli

• In vivo mechanical loading models:

  • Compare forced endurance and voluntary running protocols in wild-type and TNMD knockout mice

  • Utilize limb suspension models to study TNMD response to unloading

  • Apply controlled tendon loading followed by TNMD expression analysis

• Structural and functional assessments:

  • Use atomic force microscopy to analyze ultrastructural changes in response to mechanical loading

  • Perform biomechanical testing of tendons after various loading regimens

  • Conduct gene expression profiling of collagen crosslinking genes and proteoglycans in loaded tissues